BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38236941)

  • 21. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
    McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T
    Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis.
    Park JM; Wu T; Cyr AR; Woodfield GW; De Andrade JP; Spanheimer PM; Li T; Sugg SL; Lal G; Domann FE; Zhang W; Weigel RJ
    Oncogene; 2015 Dec; 34(50):6105-14. PubMed ID: 25772240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The LIM domain binding protein 1, Ldb1, has distinct roles in Neu-induced mammary tumorigenesis.
    Ahmed S; Pryce BR; Al-Zahrani KN; Sabourin LA
    Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt A):1590-1597. PubMed ID: 30327200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis.
    Dearth RK; Kuiatse I; Wang YF; Liao L; Hilsenbeck SG; Brown PH; Xu J; Lee AV
    BMC Cancer; 2011 Aug; 11():377. PubMed ID: 21867536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo.
    Lahlou H; Sanguin-Gendreau V; Frame MC; Muller WJ
    Breast Cancer Res; 2012 Feb; 14(1):R36. PubMed ID: 22373082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss.
    Lozy F; Cai-McRae X; Teplova I; Price S; Reddy A; Bhanot G; Ganesan S; Vazquez A; Karantza V
    Autophagy; 2014 Apr; 10(4):662-76. PubMed ID: 24492513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
    Sacco MG; Barbieri O; Piccini D; Noviello E; ZoppƩ M; Zucchi I; Frattini A; Villa A; Vezzoni P
    Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.
    Menezes ME; Shen XN; Das SK; Emdad L; Guo C; Yuan F; Li YJ; Archer MC; Zacksenhaus E; Windle JJ; Subler MA; Ben-David Y; Sarkar D; Wang XY; Fisher PB
    Oncotarget; 2015 Nov; 6(35):36928-42. PubMed ID: 26474456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caloric restriction inhibits mammary tumorigenesis in MMTV-ErbB2 transgenic mice through the suppression of ER and ErbB2 pathways and inhibition of epithelial cell stemness in premalignant mammary tissues.
    Ma Z; Parris AB; Howard EW; Shi Y; Yang S; Jiang Y; Kong L; Yang X
    Carcinogenesis; 2018 Oct; 39(10):1264-1273. PubMed ID: 30107476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
    Landis MD; Seachrist DD; MontaƱez-Wiscovich ME; Danielpour D; Keri RA
    Oncogene; 2005 Aug; 24(33):5173-90. PubMed ID: 15897883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated expression of wildtype RhoC promotes ErbB2- and Pik3ca-induced mammary tumor formation.
    Raghuram N; Temel EI; Kawamata T; Kozma KJ; Loch AJ; Wang W; Adams JR; Muller WJ; Egan SE
    Breast Cancer Res; 2024 May; 26(1):86. PubMed ID: 38807216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of HER2-positive mammary tumorigenesis and metastasis.
    Nie J; Dang S; Zhu R; Lu T; Zhang W
    Breast Cancer Res; 2024 Jan; 26(1):19. PubMed ID: 38287441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.
    Campbell MJ; Wollish WS; Lobo M; Esserman LJ
    In Vitro Cell Dev Biol Anim; 2002 Jun; 38(6):326-33. PubMed ID: 12513120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Utero Exposure to Bisphenol a Promotes Mammary Tumor Risk in MMTV-Erbb2 Transgenic Mice Through the Induction of ER-erbB2 Crosstalk.
    Ma Z; Parris AB; Howard EW; Davis M; Cao X; Woods C; Yang X
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32353937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
    Maroulakou IG; Oemler W; Naber SP; Tsichlis PN
    Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
    Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
    Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promotion of breast cancer by beta-hexachlorocyclohexane in MCF10AT1 cells and MMTV-neu mice.
    Wong PS; Matsumura F
    BMC Cancer; 2007 Jul; 7():130. PubMed ID: 17640349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3.
    Young CD; Nolte EC; Lewis A; Serkova NJ; Anderson SM
    Breast Cancer Res; 2008; 10(4):R70. PubMed ID: 18700973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice.
    Niemeyer CC; Spencer-Dene B; Wu JX; Adamson ED
    Int J Cancer; 1999 May; 81(4):588-91. PubMed ID: 10225449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.